1. Stocks
    2. /
  2. Race Oncology Limited (ASX: RAC)
    3. /

Race Oncology Limited (ASX: RAC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Race Oncology Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Race Oncology Limited (ASX: RAC)
    Latest News

    A woman jumps for joy with a rocket drawn on the wall behind her.
    Healthcare Shares

    Guess which ASX All Ords share is soaring 12% on a 'key step'

    | James Mickleboro

    A positive update is getting investors very excited. What did the company announce?

    Read more »

    In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
    Healthcare Shares

    2 ASX healthcare shares racing higher on positive updates

    | James Mickleboro

    These healthcare shares are avoiding the market weakness on Wednesday.

    Read more »

    Rising share price chart.
    Share Gainers

    Why Allkem, IGO, Northern Star, and Race Oncology shares are racing higher

    | James Mickleboro

    These ASX shares are ending the week strongly.

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Aeris Resources, Evolution, Li-S Energy, and Race Oncology shares are charging higher

    | James Mickleboro

    These ASX shares are having a strong session on Tuesday.

    Read more »

    Four people on the beach leap high into the air.
    Share Gainers

    4 ASX All Ords shares smashing the market on big news

    | Brooke Cooper

    Guess which All Ordinaries stock is soaring over 20% today.

    Read more »

    A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
    Share Fallers

    Why Block, Mincor, Race Oncology, and Weebit Nano shares are sinking today

    | James Mickleboro

    Investors have been selling these ASX shares on Friday.

    Read more »

    A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
    Share Fallers

    Why is ASX All Ords healthcare share Race Oncology plummeting 10% today?

    | Brooke Cooper

    Its got something to do with the company's chief scientific officer and director.

    Read more »

    A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
    Share Gainers

    Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

    | James Mickleboro

    These ASX shares are starting the week in a positive fashion.

    Read more »

    A woman is excited as she reads the latest rumour on her phone.
    Share Market News

    4 ASX All Ords shares insiders have been buying up in January

    | Sebastian Bowen

    These insiders are putting money where their mouths are.

    Read more »

    A man in his 30s holds his laptop and operates it with his other hand as he has a look of pleasant surprise on his face as though he is learning something new or finding hidden value in something on the screen.
    Share Market News

    This ASX All Ords director has bought 25,000 of his company's shares in a week

    | Sebastian Bowen

    This director made a big investment last week.

    Read more »

    A young female ASX investor sits at her desk with her fists raised in excitement as she reads about rising ASX share prices on her laptop.
    Share Gainers

    Why Cogstate, Mayne Pharma, Race Oncology, and Whitehaven Coal are charging higher

    | James Mickleboro

    These ASX shares are on form on Wednesday...

    Read more »

    Three rock climbers hang precariously off a steep cliff face, each connected to the other with the higher person holding on and the two below them connected by their arms and rope but not making contact with the cliff face.
    Earnings Results

    3 ASX All Ords shares tumbling lower following full-year results

    | Mitchell Lawler

    These ASX All Ords shares took a bath on Monday following earnings...

    Read more »

    Frequently Asked Questions

    No, Race Oncology does not pay dividends at this time.

    Sydney-headquartered Race Oncology Ltd listed on the ASX on 13 July 2016.

    RAC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Race Oncology Limited

    Race Oncology Ltd (ASX: RAC) is a clinical-stage global biotechnology company focused on cancer care.

    Race’s lead asset, bisantrene, is a small-molecule anthracene chemotherapeutic. It has demonstrated anti-cancer and cardio-protection effects in 46 clinical trials and around 70 peer-reviewed publications.

    The company is now taking its next-generation bisantrene to new fields of cancer treatment. It is initially focusing on two areas of unmet need: metastatic breast cancer (lead indication) and acute myeloid leukaemia (AML).

    As part of its business strategy and clinical program, Race is also investigating the impact bisantrene and new molecules have on the m6A RNA pathway. This follows independent research describing bisantrene as the most potent inhibitor of fat mass and obesity-associated protein (FTO). Dysregulation of RNA (or the over-expression of FTO) has been shown to be a driver of a diverse range of cancers. Race and its partners are now in pre-clinical studies to explore the synergies and impact of bisantrene on FTO regulation.

    Profile

    since

    Note